Cabinet Secretary (CS) Duale Leads Consultative Meeting on Operationalizing Kenya National Public Health Institute
The KNPHI will be anchored on five strategic pillars: Surveillance and health security, Emergency preparedness and response, Laboratory strengthening ,Public health research and Public health workforce development.
These pillars are designed to strengthen Kenya's public health system, promote equity, and enhance preparedness for infectious disease threats.
CS Duale emphasized the need to build a responsive, people-centered health system that fosters trust and improves national health outcomes. 'The prosperity of any nation is measured by the health of its citizens,' he stated.
He also underscored the importance of a transparent and factual flow of information, grounded in integrity and professionalism, especially as the Ministry moves forward with reforms to support the rollout of Universal Health Coverage (UHC).
Present at the meeting were Principal Secretaries Dr. Ouma Oluga (Medical Services) and Ms. Mary Muthoni (Public Health and Professional Standards), along with the Director General for Health, Dr. Patrick Amoth.
Distributed by APO Group on behalf of Ministry of Health, Kenya.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
3 days ago
- Zawya
Kenya certified for elimination of human African trypanosomiasis (sleeping sickness)
The World Health Organization (WHO) has validated Kenya as having eliminated human African trypanosomiasis (HAT) or sleeping sickness as a public health problem, making it the tenth country to reach this important milestone. HAT is the second neglected tropical disease (NTD) to be eliminated in Kenya: the country was certified free of Guinea worm disease in 2018. 'I congratulate the government and people of Kenya on this landmark achievement,' said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. 'Kenya joins the growing ranks of countries freeing their populations of human African trypanosomiasis. This is another step towards making Africa free of neglected tropical diseases'. HAT a vector-borne disease caused by the blood parasite Trypanosoma brucei. It is transmitted to humans through the bites of tsetse flies that have acquired the parasites from infected humans or animals. Rural populations dependent on agriculture, fishing, animal husbandry or hunting are most at risk of exposure. As the name indicates, HAT is transmitted only on the African continent. The disease exists in two forms, gambiense and rhodesiense. The rhodesiense form, which is found in eastern and southern Africa, is the only one present in Kenya. It is caused by Trypanosoma brucei rhodesiense (r-HAT) and progresses rapidly invading multiple organs including the brain. Without treatment, it is fatal within weeks. Kenya's progress 'This validation marks a major public health milestone for Kenya, as we celebrate the elimination of a deadly disease in our country. The achievement will not only protect our people but also pave the way for renewed economic growth and prosperity,' said Dr Aden Duale, Kenya's Cabinet Secretary for Health. 'This follows many years of dedication, hard work and collaboration'. The first cases of HAT in Kenya were detected in the early 20 century. Since then, Kenya has engaged in consistent control activities, without indigenous new cases reported for over 10 years. The last autochthonous case was detected in 2009, and the last two exported cases, infected in the Masai Mara National Reserve, were detected in 2012. Recently, Kenya strengthened HAT surveillance in 12 health facilities in six historically endemic counties to act as sentinel sites. They were equipped with diagnostic tools and had their clinical personnel trained on diagnostic procedures, including the most sensitive and practical tests for r-HAT. The country also actively monitors the control and surveillance of tsetse flies and animal trypanosomiasis, both within and beyond the historical HAT endemic areas, supported by the national veterinary health authorities and the Kenya Tsetse and Trypanosomiasis Eradication Council (KENTTEC). These activities and the related data provide supplementary backing to the claim of HAT elimination as a public health problem. 'This key milestone reflects Kenya's efforts and commitment over many years, as a collaboration between national and county governments, national research institutions, development partners and affected communities,' said Dr Patrick Amoth, EBS, Director General Health, Ministry of Health, Kenya. 'The country remains fully committed to sustain the quality of care and surveillance in line with WHO's recommendations'. Supported by WHO and partners, including FIND, Kenya's HAT elimination programme will now implement a post-validation surveillance plan to detect any potential resurgence or reintroduction of transmission. WHO continues to support ongoing monitoring in previously affected areas and maintains a stock of medicines to ensure rapid treatment of possible future cases, thanks to donations from Bayer AG and Sanofi. 'This success was made possible by the Ministry of Health's leadership, the dedication of health workers in areas at risk and the support from key partners,' said Dr Abdourahmane Diallo, WHO Representative to Kenya. 'WHO is proud to have contributed to this achievement and encourages all stakeholders to remain involved in post-validation monitoring'. Progress in global HAT elimination A total of 57 countries have eliminated at least one NTD. Of these, 10 (including Kenya) have successfully eliminated HAT as a public health problem. The other countries that have reached this milestone are Benin, Chad, Côte d'Ivoire, Equatorial Guinea, Ghana, Guinea, Rwanda, Togo and Uganda. Distributed by APO Group on behalf of World Health Organization - Kenya.
Zawya
3 days ago
- Zawya
FIND Congratulates Kenya for Eliminating Human African Trypanosomiasis as a Public Health Problem
FIND ( congratulates Kenya's Ministry of Health (MoH) on today's announcement by the World Health Organization (WHO) that Kenya has successfully eliminated human African trypanosomiasis (HAT), commonly known as 'sleeping sickness' as a public health problem. 'This is an incredible achievement and and is testimony to what can be accomplished through the investment and dedication of partners striving towards a common goal,' said Dr Ifedayo Adetifa, CEO and Chief Transformation Officer of FIND. 'FIND is very proud of being an integral part of bringing diagnosis to all, a critical step in eliminating this deadly disease.' FIND has worked hand in hand with the MoH since 2020 to strengthen the country's capacity for diagnosis and surveillance of HAT in the endemic regions of the country. Historically, diagnosing the disease and monitoring its spread – crucial steps for any elimination effort – have been a challenge, because many of the communities most vulnerable to HAT live in remote, rural settings. 'Eliminating neglected tropical diseases is even more critical at this point in history, said FIND Board Chair Dr Ayoade Alakija, 'as health financing in low- and middle-income countries becomes increasingly challenging and new models are being proposed. By their very definition, most diseases affecting the most vulnerable are 'neglected', thus the elimination of HAT is an important milestone and reflects what is possible when leaders in the private and public spheres deliver comprehensively on prevention, early diagnosis, and effective treatment.' Through FIND's support, all health facilities in the HAT-endemic regions were mapped and the laboratory infrastructure was upgraded, which included the installation of appropriate diagnostic equipment in strategically located health facilities. All health workers (both clinicians and lab workers) were re-trained in the clinical diagnosis and treatment of HAT. This was supported by a campaign to raise awareness in communities, health care workers, and policymakers about HAT, its manifestation, and where to report for testing. Additionally, FIND strengthened the disease surveillance system and established a system for the collection and reporting of HAT surveillance data to the MoH and worked closely with the Ministry in the preparation and submission of the dossier on HAT elimination to WHO. Prof. Joseph Ndungu, Head of FIND's Kenya office, said, 'HAT causes tremendous suffering, typically in communities that are already vulnerable. Eliminating this deadly disease as a public health problem is an important victory, and FIND is gratified to have been able to support Kenya in their efforts through strengthening the country's capacity and its surveillance systems.' HAT, also known as sleeping sickness, is a vector-borne disease caused by blood parasites (Trypanosoma brucei), transmitted to humans by bites of tsetse flies which have acquired the parasites from infected humans or animals. Rural populations which depend on agriculture, fishing, animal husbandry or hunting are the most exposed. Kenya is the 10th country to have successfully eliminated HAT as a public health problem. As the name indicates, HAT is transmitted only on the African continent. The disease exists in two forms, gambiense and rhodesiense. The rhodesiense form, which is found in eastern and southern Africa, including Kenya, is caused by Trypanosoma brucei rhodesiense, and presents as an acute disease that develops rapidly with multi-organ invasion, including the brain. Without treatment, rhodesiense sleeping sickness is fatal within a few days or weeks. Distributed by APO Group on behalf of FIND.
Khaleej Times
5 days ago
- Khaleej Times
Dubai residents call out 'disrespectful' vaping in malls amid rising inspections
Dubai Municipality has stepped up inspections in shopping centres across the emirate after receiving complaints about people vaping indoors, in violation of UAE laws banning smoking and e-cigarettes in enclosed public spaces. In response to the complaint, which raised concerns about the rising number of people using vapes in malls, the authority confirmed that several measures are already in place to curb the behaviour. 'Dubai Municipality, represented by the Health and Safety Department, has taken a set of measures in coordination with shopping centre operators to address the smoking phenomenon,' the authority said in a statement on X. These include installing clear signage at entrances and corridors, requiring security guards to monitor and alert violators, and issuing instructions to shops and restaurants to enforce the ban. Smoking near entrances and exits is also prohibited, with designated areas located at least seven metres away from such spots. The authority also confirmed it conducts regular inspection rounds to ensure compliance, with the goal of 'protecting public health and promoting a smoke-free environment". Despite the municipality's actions and multiple warnings, some residents say vaping indoors is still a common sight. 'It feels disrespectful,' said Sana Rahim, a Sharjah-based mother of two who frequently visits Dubai malls with her children. 'You're walking with your kids and suddenly someone walks past blowing vape smoke. It's not just unpleasant, it's sending the wrong message to children — that this is normal and acceptable behaviour indoors.' Sana added that the issue feels out of place in a country known for its order and respect for public spaces. 'UAE residents and citizens are known for being law-abiding and sophisticated. This is a new sight and something we hadn't seen before,' she said. 'Even if it's an electronic cigarette and not a real cigarette and doesn't produce any waste, that's not the reason for banning it inside. This isn't its place.' Vaping laws in the UAE While the sale of vaping devices and e-liquids has been legal in the UAE since mid-April 2019 under strict regulations set by the Emirates Authority for Standardisation and Metrology (Esma), the law clearly prohibits their use indoors. That includes malls, offices, airports (except in designated areas), and hospitals. Dubai Municipality has also banned smoking shisha in parks, beaches, and public recreational spaces. It requires special licences for shisha cafes, which must not operate within 150 metres of schools, mosques, or residential areas. Pregnant women are not allowed to enter shisha cafes, even if they don't intend to smoke. Another resident, Saeed Al Mazrouei, said he recently witnessed a teenager vaping openly at a food court. 'No one said anything to him. There were families around, young kids, and it's like no one cared,' he said. 'Just because it smells like bubble gum doesn't make it any less harmful.' Not a grey area, doctors say While some people may view vaping as a 'healthier' alternative to smoking, doctors continue to warn against the risks of both direct and second-hand exposure. Speaking to Khaleej Times, Dr Biniyam Tefera, a consultant pulmonologist based in Dubai, said second-hand vape aerosol can carry health risks, especially in non-ventilated areas like malls. 'People often assume that because vape smoke looks less dense or smells pleasant, it's safe, but that's not the case,' said Dr Tefera. 'Second-hand vape exposure can contain nicotine, heavy metals, and other harmful chemicals. Over time, this can affect lung function, especially in children, elderly people, and those with respiratory conditions.' He noted that even brief exposure in confined public areas could pose risks to people with asthma or underlying lung issues. 'The chemicals inhaled aren't just water vapour, and that misconception is dangerous,' he said. 'The long-term impact of chronic passive exposure is still being studied, but what we already know is enough to justify stricter enforcement.' He added that enforcing vape-free zones in malls is 'not just a policy issue, but a health protection matter".
